Thor Medical ASA (OSL:TRMED)
Norway flag Norway · Delayed Price · Currency is NOK
2.415
-0.005 (-0.21%)
Apr 1, 2025, 3:40 PM CET

Thor Medical ASA Statistics

Total Valuation

OSL:TRMED has a market cap or net worth of NOK 754.58 million. The enterprise value is 631.93 million.

Market Cap 754.58M
Enterprise Value 631.93M

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

OSL:TRMED has 314.41 million shares outstanding. The number of shares has increased by 34.90% in one year.

Current Share Class n/a
Shares Outstanding 314.41M
Shares Change (YoY) +34.90%
Shares Change (QoQ) +1.36%
Owned by Insiders (%) 3.00%
Owned by Institutions (%) 1.73%
Float 154.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 2.00
P/TBV Ratio 13.95
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -14.97
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -26.20

Financial Position

The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.00.

Current Ratio 5.67
Quick Ratio 5.49
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.03
Interest Coverage -448.28

Financial Efficiency

Return on equity (ROE) is -13.86% and return on invested capital (ROIC) is -9.01%.

Return on Equity (ROE) -13.86%
Return on Assets (ROA) -7.37%
Return on Invested Capital (ROIC) -9.01%
Return on Capital Employed (ROCE) -11.22%
Revenue Per Employee n/a
Profits Per Employee -8.44M
Employee Count 2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +122.43% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +122.43%
50-Day Moving Average 2.41
200-Day Moving Average 1.83
Relative Strength Index (RSI) 51.93
Average Volume (20 Days) 1,913,215

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -43.93M
Pretax Income -42.64M
Net Income -42.21M
EBITDA -41.55M
EBIT -43.93M
Earnings Per Share (EPS) -0.18
Full Income Statement

Balance Sheet

The company has 123.39 million in cash and 737,000 in debt, giving a net cash position of 122.65 million or 0.39 per share.

Cash & Cash Equivalents 123.39M
Total Debt 737,000
Net Cash 122.65M
Net Cash Per Share 0.39
Equity (Book Value) 337.14M
Book Value Per Share 1.20
Working Capital 107.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.98 million and capital expenditures -140,000, giving a free cash flow of -24.12 million.

Operating Cash Flow -23.98M
Capital Expenditures -140,000
Free Cash Flow -24.12M
FCF Per Share -0.08
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OSL:TRMED does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -34.90%
Shareholder Yield -34.90%
Earnings Yield -5.59%
FCF Yield -3.20%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a